Canadian Cardiovascular Society
 
Canadian Cardiovascular Society

CCS/Pfizer/CHF Alliance Fellowship Award in FNIM Communities Experiencing Heart Function Inequities

The Canadian Cardiovascular Society, Pfizer, and the Canadian Heart Function Alliance (CHF Alliance) are proud to support the CCS/Pfizer/Canadian Heart Function Alliance Research Fellowship Award in First Nations, Inuit and Métis (FNIM) Communities Experiencing Heart Function (HF) Inequities. The purpose of this award is to support growth and excellence in research focused on better understanding and addressing the heart function inequities experienced by First Nations, Inuit and Métis, in both health generally and HF care more specifically. This award is focused on successful early career Canadian researchers familiar with diagnosing and caring for FNIM people with HF.

Application Deadline: May 7, 2024 at 12:00 p.m. ET

Apply Now
Award Handbook
Past Award Recipients

Eligibility

  • Be a CCS Member*. For more information about CCS Membership, visit the CCS website: https://ccs.ca/en/membership.
    *You must be a CCS member to accept funding, but you can apply without being a member!
  • Applicants must be a Canadian Citizen or Permanent Resident of Canada at the time funding is received.
  • Preference for applicants who agree to have their projects become part of the CHF Alliance structure and to present their protocols, project updates, results, and knowledge translation plans at internal CHF Alliance meetings. Visit the CHF Alliance website for more information about the structure: https://www.chfalliance.ca/chf-alliance.
  • The principal investigator must have completed an MD degree (or equivalent) and have obtained a fellowship from the Royal College of Physicians & Surgeons of Canada (or equivalent from a foreign country) or from the Canadian College of Family Physicians; or have completed a PharmD; or have completed a PhD (post-doc).
  • Preference for principle investigators with a proven track record in FNMI health research, with demonstrated engagement and commitment to the FNIM community. For example:
    • TCPS 2 certificate
    • Training in FNIM people and their health (certificate, transcript or a few paragraphs on key learnings)
    • Evidence of engagement with FNIM people (ie. letter of support, engagement plan, etc.)
  • Applicants must provide a letter of acceptance to a faculty or clinical position at a Canadian institution.
  • Applicants must demonstrate support by the university or institution at which the applicant will conduct the proposed research program. Requirement for a statement completed by the Dean and Department Head (or institutional equivalents) demonstrating commitment of the university or institution to provide the applicant appropriate academic rank, time allocated to the proposed research program, and to provide adequate space and facilities for the investigator’s research, as well as a commitment to developing the applicant’s research, technical and professional skills and networks over the training period by providing career planning, skills development and networking opportunities to prepare the trainee for an impactful career.
  • Preference for applicants from institutions with a demonstrable commitment to reconciliation that might support the Fellow in conducting their proposed research (for example, institutions that have offices of Indigenous engagement, agreements in place with Indigenous communities, or Elders and Knowledge Holders on staff that could support the Fellow).
  • Applicants can be principal investigators on only one application.
  • Award funds are solely intended for research performed in Canada.
  • This salary award is intended for a Fellow to perform original research that is either clinical or translational with expected impact on patient care. Proposal should not request supplemental funding for a project that has extramural funding.
    • If the submission refers to a multicenter clinical trial, the applicant must indicate their specific role in the research study.
    • If the application is for a sub-study of an ongoing project or trial, the applicant must specify their role and explain how the sub-study is distinct from the main study.
  • If funded, proposed research must be completed within 12 months (with consideration for projects up to 24 months) from the start of funding.
  • Research status reports will be required on October 1st of every year that the project is running.

Eligible Areas of Research

Award funds are solely intended for Canadian research purposes. eligible research activities must involve clinical outcomes research or clinical research in an area related to prediction, prevention, diagnosis and management of HF in the Canadian First Nations, Inuit and Métis (FNIM) communities (spanning the lifecycle of patients from young to elderly, from rural to urban, and across geographic and socio-economic barriers) with strong preference for:

  • Multi-institutional collaboration, particularly with sites involved with the CHF Alliance
  • Research proposals with demonstrable ability to meet objectives within the 12-month term of the fellowship

The Peer Review Process and Evaluation Committee

All applications will be pre-screened for eligibility. Applications that are late, incorrectly formatted, incomplete and/or do not meet the basic eligibility criteria will not be considered for review.

Peer review of all eligible applications will be conducted by a scientific review committee comprised of CCS members. Reviewers are selected for their subject matter expertise. All eligible proposals will be reviewed by at least two members of the peer review committee.

If you have any questions or require support preparing or submitting your application, please email researchawards@ccs.ca.

Supported by:

About

Back to top